Literature DB >> 8127121

Extended esophagectomy in the management of carcinoma of the upper thoracic esophagus.

W T Vigneswaran1, V F Trastek, P C Pairolero, C Deschamps, R C Daly, M S Allen.   

Abstract

Upper thoracic esophageal tumors adjacent to the trachea often require a preliminary thoracotomy to accomplish resection. Between January 1985 and July 1992, 49 consecutive patients (38 men and 11 women) underwent extended esophagectomy for esophageal cancer where the neoplasm was mobilized through an initial right thoracotomy and then resected and reconstructed through an abdomino-cervical approach. Ages ranged from 40 to 80 years (median 63.4 years). The tumor was located in the upper third of the thoracic esophagus in 44 patients and in the middle third in five. Thirty-three patients had squamous cell carcinoma, 14 had adenocarcinoma, and two had adenosquamous cell carcinoma. Complications occurred in 35 patients (71.4%) and included anastomotic leak in 15, vocal cord paralysis in 11, atrial arrhythmia in nine, pneumonia in six, wound infection in five, and postoperative bleeding in one. Three patients required tracheostomy. There was one postoperative death (2.0%). Median survival was 0.9 years (range 1 month to 5.1 years). Thirty-one patients were alive at the time this article was written, 28 without evidence of cancer. Cause of death was recurrent disease in 13 patients, unrelated to cancer in three, and unknown in one. Overall actuarial 3- and 5-year survivals were 48.6% and 18.2%, respectively. Four-year survival for stage II disease was 44.6% as compared to 24.9% for stage III (p < 0.02). The presence of lymph node metastases significantly affected survival. Three-year survival for patients with N0 disease was 77.9% compared with 20.9% for patients with N1 disease (p < 0.01). Age, sex, and cell type had no effect on survival. Ten patients had late dysphagia, four had gastroesophageal reflux, and one had dumping symptoms. Although associated with significant morbidity, we conclude that extended esophagectomy is an acceptable method of management for tumors of the upper thoracic esophagus. Mortality is low, and long-term results are reasonable.

Entities:  

Mesh:

Year:  1994        PMID: 8127121

Source DB:  PubMed          Journal:  J Thorac Cardiovasc Surg        ISSN: 0022-5223            Impact factor:   5.209


  10 in total

1.  Improvement in the results of surgical treatment of advanced squamous esophageal carcinoma during 15 consecutive years.

Authors:  N Ando; S Ozawa; Y Kitagawa; Y Shinozawa; M Kitajima
Journal:  Ann Surg       Date:  2000-08       Impact factor: 12.969

2.  Upregulation of the long noncoding RNA TUG1 promotes proliferation and migration of esophageal squamous cell carcinoma.

Authors:  Youtao Xu; Jie Wang; Mantang Qiu; Lei Xu; Ming Li; Feng Jiang; Rong Yin; Lin Xu
Journal:  Tumour Biol       Date:  2014-10-31

3.  Late course accelerated hyperfractionated radiotherapy for clinical T1-2 esophageal carcinoma.

Authors:  Kuai-Le Zhao; Yang Wang; Xue-Hui Shi
Journal:  World J Gastroenterol       Date:  2003-06       Impact factor: 5.742

4.  Transthoracic versus transhiatal esophagectomy for esophageal carcinoma: experience from a single tertiary care institution.

Authors:  Nadeem UlNazeer Kawoosa; Abdul Majeed Dar; Mukand Lal Sharma; Abdul Gani Ahangar; Ghulam Nabi Lone; Mohammad Akbar Bhat; Shyam Singh
Journal:  World J Surg       Date:  2011-06       Impact factor: 3.352

5.  Esophagectomy after anti-reflux surgery.

Authors:  K Robert Shen; Karen M Harrison-Phipps; Stephen D Cassivi; Dennis Wigle; Francis C Nichols; Mark S Allen; Christina M Wood; Claude Deschamps
Journal:  J Thorac Cardiovasc Surg       Date:  2010-04       Impact factor: 5.209

6.  Esophagogastrectomy: the influence of stapled versus hand-sewn anastomosis on outcome.

Authors:  Abdollah Behzadi; Francis C Nichols; Stephen D Cassivi; Claude Deschamps; Mark S Allen; Peter C Pairolero
Journal:  J Gastrointest Surg       Date:  2005-11       Impact factor: 3.452

7.  Functional outcome of gastrointestinal tract and quality of life after esophageal reconstruction of esophagus cancer.

Authors:  Manochehr Aghajanzadeh; Feizollah Safarpour; M Reza Koohsari; Farborz M Ghanaei; Sadigheh M Bodaghi; Hadi Tozandehgani
Journal:  Saudi J Gastroenterol       Date:  2009-01       Impact factor: 2.485

8.  Improvement in treatment results and long-term survival of patients with esophageal cancer: impact of chemoradiation and change in treatment strategy.

Authors:  Simon Law; Dora L W Kwong; Ka-Fai Kwok; Kam-Ho Wong; Kent-Man Chu; Jonathan S T Sham; John Wong
Journal:  Ann Surg       Date:  2003-09       Impact factor: 12.969

9.  Radiotherapy of 180 cases of operable esophageal carcinoma.

Authors:  D F Chen; Z Y Yang; W B Yin
Journal:  World J Gastroenterol       Date:  1997-06-15       Impact factor: 5.742

10.  Complete pathologic response after neoadjuvant chemoradiotherapy for esophageal cancer is associated with enhanced survival.

Authors:  James M Donahue; Francis C Nichols; Zhuo Li; David A Schomas; Mark S Allen; Stephen D Cassivi; Aminah Jatoi; Robert C Miller; Dennis A Wigle; K Robert Shen; Claude Deschamps
Journal:  Ann Thorac Surg       Date:  2009-02       Impact factor: 4.330

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.